June 27, 2022
Takeda Pharmaceutical said on June 24 that its wholly owned plasma business subsidiary Nihon Pharmaceutical will be merged into the company, effective October 1, excluding non-core operations. Subject to the transaction is the R&D and manufacturing functions of plasma products...read more